PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,432,000 | -37.6% | 675,286 | -1.4% | 0.00% | -33.3% |
| Q3 2016 | $2,295,000 | +6.2% | 685,096 | -0.4% | 0.00% | 0.0% |
| Q2 2016 | $2,160,000 | +5.4% | 687,978 | +11.8% | 0.00% | 0.0% |
| Q1 2016 | $2,050,000 | -5.8% | 615,620 | +0.1% | 0.00% | 0.0% |
| Q4 2015 | $2,177,000 | -29.4% | 614,958 | +0.3% | 0.00% | -25.0% |
| Q3 2015 | $3,085,000 | -21.3% | 613,242 | +0.6% | 0.00% | -20.0% |
| Q2 2015 | $3,919,000 | +24.6% | 609,426 | +36.3% | 0.01% | +25.0% |
| Q1 2015 | $3,146,000 | -7.3% | 447,124 | +1.6% | 0.00% | 0.0% |
| Q4 2014 | $3,394,000 | +2.7% | 440,177 | -0.5% | 0.00% | -20.0% |
| Q3 2014 | $3,305,000 | -22.3% | 442,480 | +0.7% | 0.01% | -16.7% |
| Q2 2014 | $4,251,000 | +15.2% | 439,201 | -1.1% | 0.01% | +20.0% |
| Q1 2014 | $3,690,000 | +12.7% | 443,990 | +14.4% | 0.01% | 0.0% |
| Q4 2013 | $3,275,000 | +3.1% | 387,990 | -2.7% | 0.01% | 0.0% |
| Q3 2013 | $3,177,000 | +10.6% | 398,593 | +7.1% | 0.01% | 0.0% |
| Q2 2013 | $2,873,000 | – | 372,104 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |